Breaking News Instant updates and real-time market news.

STJ

Acquired by ABT

$79.44

1.78 (2.29%)

07:16
10/19/16
10/19
07:16
10/19/16
07:16

St. Jude Medical reports Q3 adjusted EPS 99c, consensus $1.01

Reports Q3 revenue $1.5B, consensus $1.5B. International sales increased 13 percent as reported or 8 percent on a comparable constant currency basis, where a full portfolio of products is available. Neuromodulation sales increased 17 percent both as reported and on a constant currency basis driven by the most comprehensive product portfolio on the market. Atrial fibrillation sales increased 14 percent as reported, or 12 percent on a constant currency basis driven by strong growth across the product portfolio.

  • 19

    Oct

  • 26

    Oct

STJ Acquired by ABT
$79.44

1.78 (2.29%)

08/29/16
FBCO
08/29/16
NO CHANGE
FBCO
St. Jude Medical can fix security deficiencies, says Credit Suisse
After speaking with "a developer of software used in drugs/devices" about Muddy Waters' security concerns regarding St. Jude's CRM system, Credit Suisse analyst Matthew Keeler says the consultant believes that the security deficiencies,can be fixed. According to the consultant, the deficiencies can be fixed using a five to ten person team working for about three months, Keeler stated. Keeler does not think that St. Jude's pending acquisition by Abbott (ABT) will be impacted by Muddy Waters' report. He keeps an $81 price target and Neutral rating on St. Jude.
09/08/16
PIPR
09/08/16
NO CHANGE
Target $82
PIPR
Neutral
Piper sees little reason to believe St. Jude deal will not close
Piper Jaffray analyst Brooks West says cybersecurity expert Mark Lanterman during a conference call yesterday refuted security claims by MedSec and Muddy Waters against St. Jude Medical's (STJ) pacemakers, defibrillators and Merlin monitoring system. Lanterman stated that there is "not much meat on the bone" to the MedSec claims and the quality of the analysis, West tells investors in a research note. He notes that Abbott (ABT) yesterday at a competitor conference earlier stated the St. Jude acquisition was progressing toward a close before year-end. The analyst sees little reason to believe the transaction will not close in the planned timeframe. West reiterates a Neutral rating on St. Jude.
09/19/16
JEFF
09/19/16
NO CHANGE
Target $48
JEFF
Buy
Abbott unit sale does not impact Alere transaction, says Jefferies
Jefferies analyst Jeffrey Holford believes Abbott's (ABT) sale of its Medical Optics business to Johnson & Johnson (JNJ) does not imply an increased probability that the Alere (ALR) deal will close. After speaking to Abbott management, Holford thinks the proceeds from the sale are more likely to be targeted towards the St. Jude Medical (STJ) acquisition. He believes that deal has a higher probability of closing than Alere. Holford has a Buy rating on Abbott with a $48 price target.
10/11/16
COWN
10/11/16
NO CHANGE
Target $85
COWN
Outperform
Cowen says St. Jude advisory common for the industry
While Dear Doctor letters are never a positive, St. Jude Medical's (STJ) medical device advisory relating to a low rate of premature battery depletion in the high voltage portfolio is common in the Cardiac Rhythm Management industry, Cowen analyst Joshua Jennings tells investors in a research note. The analyst sees limited risk to St. Jude's franchise and still expects the takeover by Abbott Laboratories' (ABT) to close by the end of the year. Jennings keeps an Outperform rating on St. Jude shares with an $85 price target. The stock is down 1% to $80.19 in pre-market trading.

TODAY'S FREE FLY STORIES

AAPL

Apple

$150.55

-1.34 (-0.88%)

, FIT

Fitbit

$6.54

0.1 (1.55%)

12:08
09/26/17
09/26
12:08
09/26/17
12:08
Hot Stocks
Apple, Fitbit among nine selected for FDA digital pilot program »

The Food and Drug…

AAPL

Apple

$150.55

-1.34 (-0.88%)

FIT

Fitbit

$6.54

0.1 (1.55%)

JNJ

Johnson & Johnson

$131.23

0.06 (0.05%)

RHHBY

Roche

$32.00

-0.02 (-0.06%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 17

    Oct

  • 22

    Oct

  • 30

    Nov

  • 07

    Dec

  • 11

    Dec

OPK

OPKO Health

$6.87

0.16 (2.38%)

12:05
09/26/17
09/26
12:05
09/26/17
12:05
Options
Opko Health call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

PSO

Pearson

$7.78

-0.04 (-0.51%)

12:03
09/26/17
09/26
12:03
09/26/17
12:03
Downgrade
Pearson rating change  »

Pearson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.A

Lionsgate

$31.12

-0.16 (-0.51%)

12:02
09/26/17
09/26
12:02
09/26/17
12:02
Conference/Events
Lionsgate management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 27

    Sep

  • 29

    Sep

LGF.A

Lionsgate

$31.12

-0.16 (-0.51%)

12:00
09/26/17
09/26
12:00
09/26/17
12:00
Conference/Events
Lionsgate management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 29

    Sep

PDS

Precision Drilling

$3.11

0.02 (0.65%)

12:00
09/26/17
09/26
12:00
09/26/17
12:00
Conference/Events
Precision Drilling management to meet with Evercore ISI »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

LUXTY

Luxottica

$55.99

-0.36 (-0.64%)

12:00
09/26/17
09/26
12:00
09/26/17
12:00
Hot Stocks
EU opens in-depth probe into proposed Luxottica, Essilor merger »

The European Commission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
09/26/17
09/26
11:55
09/26/17
11:55
Conference/Events
William Blair medical technology analyst holds analyst/industry conference call »

Medical Technology…

UBNT

Ubiquiti

$55.43

1.25 (2.31%)

11:55
09/26/17
09/26
11:55
09/26/17
11:55
Conference/Events
Ubiquiti to hold a conference call »

Chairman, Founder &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Nov

EA

Electronic Arts

$114.20

-4.3 (-3.63%)

11:50
09/26/17
09/26
11:50
09/26/17
11:50
Options
1.8K Electronic Arts Nov 115 - 125 call spreads for $3.25 »

1.8K Electronic Arts Nov…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IGT

International Game

$24.32

1.07 (4.60%)

11:45
09/26/17
09/26
11:45
09/26/17
11:45
Options
International Game call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:45
09/26/17
09/26
11:45
09/26/17
11:45
General news
Treasury's $35 B 4-week bill sale was on the soft side »

Treasury's $35 B…

AXON

Axovant Sciences

$24.25

-0.74 (-2.96%)

11:38
09/26/17
09/26
11:38
09/26/17
11:38
Recommendations
Axovant Sciences analyst commentary  »

JMP Securities keeps…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

HES

Hess Corp.

$46.00

-0.1 (-0.22%)

11:35
09/26/17
09/26
11:35
09/26/17
11:35
Options
Hess Corp. put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

11:35
09/26/17
09/26
11:35
09/26/17
11:35
General news
Breaking General news story  »

Federal Reserve Chair…

11:34
09/26/17
09/26
11:34
09/26/17
11:34
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

RLJE

RLJ Entertainment

$3.38

-0.22 (-6.11%)

11:30
09/26/17
09/26
11:30
09/26/17
11:30
Conference/Events
RLJ Entertainment management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

FPO

First Potomac

$11.15

0.005 (0.04%)

, GOV

Government Properties

$18.76

0.32 (1.74%)

11:30
09/26/17
09/26
11:30
09/26/17
11:30
Hot Stocks
First Potomac shareholders approve acquisition by Government Properties »

First Potomac Realty…

FPO

First Potomac

$11.15

0.005 (0.04%)

GOV

Government Properties

$18.76

0.32 (1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

11:30
09/26/17
09/26
11:30
09/26/17
11:30
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

MBI

MBIA

$9.57

-0.26 (-2.65%)

11:29
09/26/17
09/26
11:29
09/26/17
11:29
Conference/Events
MBIA management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

GPRO

GoPro

$11.18

0.43 (4.00%)

11:25
09/26/17
09/26
11:25
09/26/17
11:25
Options
GoPro call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:25
09/26/17
09/26
11:25
09/26/17
11:25
Conference/Events
Federal Reserve Bank of Atlanta President speaks on the economic outlook »

Atlanta Federal Reserve…

GNCA

Genocea

11:24
09/26/17
09/26
11:24
09/26/17
11:24
Downgrade
Genocea rating change  »

Genocea downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

SYT

Syngenta

$92.04

-0.0399 (-0.04%)

11:19
09/26/17
09/26
11:19
09/26/17
11:19
Periodicals
Breaking Periodicals news story on Syngenta »

Syngenta settles…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

11:17
09/26/17
09/26
11:17
09/26/17
11:17
Periodicals
Citibank in talks with South Africa over $135M airline loan, Reuters reports »

South Africa and Citibank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.